FREE Webinar
Thursday, December 10, 2020
2:00 - 3:30 PM, Eastern Standard Time
Cell and gene therapies are revolutionizing next-generation therapeutics. Many researchers are now leveraging the power of CRISPR precision genome engineering in their cell and gene therapies research, from fixing mutations associated with disease to modifying immune cells to attack cancer. In this webinar, brought to you by Synthego, cell and gene therapy experts will discuss the applications of CRISPR in studying genetic diseases and beyond.
Topics to be covered
Meet the Speakers:
Robert Deans, PhD
Chief Scientific Officer
Synthego
Bruce Conklin, MD
Senior Investigator, Gladstone Institutes
Deputy Director, Innovative Genomics Institute
Professor, Departments of Medicine, Pharmacology, and Ophthalmology
University of California, San Francisco